Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-03 · accession 0001567619-22-002518 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-04 | 2022-02-03 | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $20.48 | -583 | 75.5K | -0.8% | -$11.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-03 | F | D | 583 | $20.48 | 75,498 | D | — | — | (F1) The exempt disposition of 583 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 3, 2020. |